Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 91 entries
Sorted by: Best Match Show Resources per page
Dr. Ram Verma, cytogeneticist 1946-2000.

American journal of medical genetics

Babu A, Lubs HA, Macera M, Patil S, Wyandt H.
PMID: 11241485
Am J Med Genet. 2001 Mar 15;99(3):179-80. doi: 10.1002/1096-8628(2001)9999:9999<::aid-ajmg1171>3.0.co;2-7.

No abstract available.

Cite
Babu A, Lubs HA, Macera M, et al. Dr. Ram Verma, cytogeneticist 1946-2000. Am J Med Genet. 2001;99(3):179-80doi: 10.1002/1096-8628(2001)9999:9999<::aid-ajmg1171>3.0.co;2-7.
Babu, A., Lubs, H. A., Macera, M., Patil, S., & Wyandt, H. (2001). Dr. Ram Verma, cytogeneticist 1946-2000. American journal of medical genetics, 99(3), 179-80. https://doi.org/10.1002/1096-8628(2001)9999:9999<::aid-ajmg1171>3.0.co;2-7
Babu, A, et al. "Dr. Ram Verma, cytogeneticist 1946-2000." American journal of medical genetics vol. 99,3 (2001): 179-80. doi: https://doi.org/10.1002/1096-8628(2001)9999:9999<::aid-ajmg1171>3.0.co;2-7
Babu A, Lubs HA, Macera M, Patil S, Wyandt H. Dr. Ram Verma, cytogeneticist 1946-2000. Am J Med Genet. 2001 Mar 15;99(3):179-80. doi: 10.1002/1096-8628(2001)9999:9999<::aid-ajmg1171>3.0.co;2-7. PMID: 11241485.
Copy Download .nbib Format: NLM
Unexplained Graft Dysfunction after Heart Transplantation-Role of Novel Molecular Expression Test Score and QTc-Interval: A Case Report.

Cardiology research and practice

Shahzad K, Cadeiras M, Arai K, Abramov D, Burke E, Deng MC.
PMID: 20672049
Cardiol Res Pract. 2010;2010:230810. doi: 10.4061/2010/230810. Epub 2010 Jun 22.

In the current era of immunosuppressive medications there is increased observed incidence of graft dysfunction in the absence of known histological criteria of rejection after heart transplantation. A noninvasive molecular expression diagnostic test was developed and validated to rule...

Cite
Shahzad K, Cadeiras M, Arai K, et al. Unexplained Graft Dysfunction after Heart Transplantation-Role of Novel Molecular Expression Test Score and QTc-Interval: A Case Report. Cardiol Res Pract. 2010;2010:230810doi: 10.4061/2010/230810.
Shahzad, K., Cadeiras, M., Arai, K., Abramov, D., Burke, E., & Deng, M. C. (2010). Unexplained Graft Dysfunction after Heart Transplantation-Role of Novel Molecular Expression Test Score and QTc-Interval: A Case Report. Cardiology research and practice, 2010230810. https://doi.org/10.4061/2010/230810
Shahzad, Khurram, et al. "Unexplained Graft Dysfunction after Heart Transplantation-Role of Novel Molecular Expression Test Score and QTc-Interval: A Case Report." Cardiology research and practice vol. 2010 (2010): 230810. doi: https://doi.org/10.4061/2010/230810
Shahzad K, Cadeiras M, Arai K, Abramov D, Burke E, Deng MC. Unexplained Graft Dysfunction after Heart Transplantation-Role of Novel Molecular Expression Test Score and QTc-Interval: A Case Report. Cardiol Res Pract. 2010;2010:230810. doi: 10.4061/2010/230810. Epub 2010 Jun 22. PMID: 20672049; PMCID: PMC2905689.
Copy Download .nbib Format: NLM
Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists.

ACS medicinal chemistry letters

Cox JM, Chu HD, Chelliah MV, Debenham JS, Eagen K, Lan P, Lombardo M, London C, Plotkin MA, Shah U, Sun Z, Vaccaro HM, Venkatraman S, Suzuki T, Wang N, Ashley ER, Crespo A, Madeira M, Leung DH, Alleyne C, Ogawa AM, Souza S, Thomas-Fowlkes B, Di Salvo J, Weinglass A, Kirkland M, Pachanski M, Powles MA, Tozzo E, Akiyama TE, Ujjainwalla F, Tata JR, Sinz CJ.
PMID: 28105274
ACS Med Chem Lett. 2016 Nov 17;8(1):49-54. doi: 10.1021/acsmedchemlett.6b00360. eCollection 2017 Jan 12.

Type 2 diabetes mellitus (T2DM) is an ever increasing worldwide epidemic, and the identification of safe and effective insulin sensitizers, absent of weight gain, has been a long-standing goal of diabetes research. G-protein coupled receptor 120 (GPR120) has recently...

Cite
Cox JM, Chu HD, Chelliah MV, et al. Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists. ACS Med Chem Lett. 2016;8(1):49-54doi: 10.1021/acsmedchemlett.6b00360.
Cox, J. M., Chu, H. D., Chelliah, M. V., Debenham, J. S., Eagen, K., Lan, P., Lombardo, M., London, C., Plotkin, M. A., Shah, U., Sun, Z., Vaccaro, H. M., Venkatraman, S., Suzuki, T., Wang, N., Ashley, E. R., Crespo, A., Madeira, M., Leung, D. H., Alleyne, C., Ogawa, A. M., Souza, S., Thomas-Fowlkes, B., Di Salvo, J., Weinglass, A., Kirkland, M., Pachanski, M., Powles, M. A., Tozzo, E., Akiyama, T. E., Ujjainwalla, F., Tata, J. R., & Sinz, C. J. (2017). Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists. ACS medicinal chemistry letters, 8(1), 49-54. https://doi.org/10.1021/acsmedchemlett.6b00360
Cox, Jason M, et al. "Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists." ACS medicinal chemistry letters vol. 8,1 (2017): 49-54. doi: https://doi.org/10.1021/acsmedchemlett.6b00360
Cox JM, Chu HD, Chelliah MV, Debenham JS, Eagen K, Lan P, Lombardo M, London C, Plotkin MA, Shah U, Sun Z, Vaccaro HM, Venkatraman S, Suzuki T, Wang N, Ashley ER, Crespo A, Madeira M, Leung DH, Alleyne C, Ogawa AM, Souza S, Thomas-Fowlkes B, Di Salvo J, Weinglass A, Kirkland M, Pachanski M, Powles MA, Tozzo E, Akiyama TE, Ujjainwalla F, Tata JR, Sinz CJ. Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists. ACS Med Chem Lett. 2016 Nov 17;8(1):49-54. doi: 10.1021/acsmedchemlett.6b00360. eCollection 2017 Jan 12. PMID: 28105274; PMCID: PMC5238469.
Copy Download .nbib Format: NLM
Challenges and solutions in the development of genomic biomarker panels: a systematic phased approach.

Current genomics

Shahzad K, Fatima A, Cadeiras M, Wisniewski N, Bondar G, Cheng R, Reed E, Deng M.
PMID: 23204923
Curr Genomics. 2012 Jun;13(4):334-41. doi: 10.2174/138920212800793339.

In the post-genome era, high throughput gene expression profiling has been successfully used to develop genomic biomarker panels (GBP) that can be integrated into clinical decision making. The development of GBPs in the context of personalized medicine is a...

Cite
Shahzad K, Fatima A, Cadeiras M, et al. Challenges and solutions in the development of genomic biomarker panels: a systematic phased approach. Curr Genomics. 2012;13(4):334-41doi: 10.2174/138920212800793339.
Shahzad, K., Fatima, A., Cadeiras, M., Wisniewski, N., Bondar, G., Cheng, R., Reed, E., & Deng, M. (2012). Challenges and solutions in the development of genomic biomarker panels: a systematic phased approach. Current genomics, 13(4), 334-41. https://doi.org/10.2174/138920212800793339
Shahzad, K, et al. "Challenges and solutions in the development of genomic biomarker panels: a systematic phased approach." Current genomics vol. 13,4 (2012): 334-41. doi: https://doi.org/10.2174/138920212800793339
Shahzad K, Fatima A, Cadeiras M, Wisniewski N, Bondar G, Cheng R, Reed E, Deng M. Challenges and solutions in the development of genomic biomarker panels: a systematic phased approach. Curr Genomics. 2012 Jun;13(4):334-41. doi: 10.2174/138920212800793339. PMID: 23204923; PMCID: PMC3394121.
Copy Download .nbib Format: NLM
Electroactive γ-Phase, Enhanced Thermal and Mechanical Properties and High Ionic Conductivity Response of Poly (Vinylidene Fluoride)/Cellulose Nanocrystal Hybrid Nanocomposites.

Materials (Basel, Switzerland)

Lizundia E, Reizabal A, Costa CM, Maceiras A, Lanceros-Méndez S.
PMID: 32041217
Materials (Basel). 2020 Feb 06;13(3). doi: 10.3390/ma13030743.

Cellulose nanocrystals (CNCs) were incorporated into poly (vinylidene fluoride) (PVDF) to tailor the mechanical and dielectric properties of this electroactive polymer. PVDF/CNC nanocomposites with concentrations up to 15 wt.% were prepared by solvent-casting followed by quick vacuum drying in...

Cite
Lizundia E, Reizabal A, Costa CM, et al. Electroactive γ-Phase, Enhanced Thermal and Mechanical Properties and High Ionic Conductivity Response of Poly (Vinylidene Fluoride)/Cellulose Nanocrystal Hybrid Nanocomposites. Materials (Basel). 2020;13(3)doi: 10.3390/ma13030743.
Lizundia, E., Reizabal, A., Costa, C. M., Maceiras, A., & Lanceros-Méndez, S. (2020). Electroactive γ-Phase, Enhanced Thermal and Mechanical Properties and High Ionic Conductivity Response of Poly (Vinylidene Fluoride)/Cellulose Nanocrystal Hybrid Nanocomposites. Materials (Basel, Switzerland), 13(3), . https://doi.org/10.3390/ma13030743
Lizundia, Erlantz, et al. "Electroactive γ-Phase, Enhanced Thermal and Mechanical Properties and High Ionic Conductivity Response of Poly (Vinylidene Fluoride)/Cellulose Nanocrystal Hybrid Nanocomposites." Materials (Basel, Switzerland) vol. 13,3 (2020). doi: https://doi.org/10.3390/ma13030743
Lizundia E, Reizabal A, Costa CM, Maceiras A, Lanceros-Méndez S. Electroactive γ-Phase, Enhanced Thermal and Mechanical Properties and High Ionic Conductivity Response of Poly (Vinylidene Fluoride)/Cellulose Nanocrystal Hybrid Nanocomposites. Materials (Basel). 2020 Feb 06;13(3). doi: 10.3390/ma13030743. PMID: 32041217; PMCID: PMC7040804.
Copy Download .nbib Format: NLM
Olive Stones as Filler for Polymer-Based Composites: A Review.

Materials (Basel, Switzerland)

Valvez S, Maceiras A, Santos P, Reis PNB.
PMID: 33578872
Materials (Basel). 2021 Feb 10;14(4). doi: 10.3390/ma14040845.

Olives' consumption produces copious agricultural byproducts that have accompanied humanity for millennia, but the increasing worldwide production complicates its management. Most wastes are generated during olive oil production in form of olive stones and other lignocellulosic derivatives. Industrial processes...

Cite
Valvez S, Maceiras A, Santos P, et al. Olive Stones as Filler for Polymer-Based Composites: A Review. Materials (Basel). 2021;14(4)doi: 10.3390/ma14040845.
Valvez, S., Maceiras, A., Santos, P., & Reis, P. N. B. (2021). Olive Stones as Filler for Polymer-Based Composites: A Review. Materials (Basel, Switzerland), 14(4), . https://doi.org/10.3390/ma14040845
Valvez, Sara, et al. "Olive Stones as Filler for Polymer-Based Composites: A Review." Materials (Basel, Switzerland) vol. 14,4 (2021). doi: https://doi.org/10.3390/ma14040845
Valvez S, Maceiras A, Santos P, Reis PNB. Olive Stones as Filler for Polymer-Based Composites: A Review. Materials (Basel). 2021 Feb 10;14(4). doi: 10.3390/ma14040845. PMID: 33578872; PMCID: PMC7916563.
Copy Download .nbib Format: NLM
Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to P. aeruginosa: a meta-analysis.

International journal of antimicrobial agents

Onorato L, Macera M, Calò F, Cirillo P, Caprio GD, Coppola N.
PMID: 34971728
Int J Antimicrob Agents. 2021 Dec 28;106512. doi: 10.1016/j.ijantimicag.2021.106512. Epub 2021 Dec 28.

OBJECTIVES: . The aim of the present meta-analysis was to compare the clinical and microbiological outcomes of patients treated with beta-lactam monotherapy or combination therapy for Pseudomonas aeruginosa infections.DATA SOURCES: MEDLINE, Google Scholar and the Cochrane Library STUDY ELIGIBILITY...

Cite
Onorato L, Macera M, Calò F, et al. Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to P. aeruginosa: a meta-analysis. Int J Antimicrob Agents. 2021;106512doi: 10.1016/j.ijantimicag.2021.106512.
Onorato, L., Macera, M., Calò, F., Cirillo, P., Caprio, G. D., & Coppola, N. (2021). Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to P. aeruginosa: a meta-analysis. International journal of antimicrobial agents, 106512. https://doi.org/10.1016/j.ijantimicag.2021.106512
Onorato, Lorenzo, et al. "Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to P. aeruginosa: a meta-analysis." International journal of antimicrobial agents vol. (2021): 106512. doi: https://doi.org/10.1016/j.ijantimicag.2021.106512
Onorato L, Macera M, Calò F, Cirillo P, Caprio GD, Coppola N. Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to P. aeruginosa: a meta-analysis. Int J Antimicrob Agents. 2021 Dec 28;106512. doi: 10.1016/j.ijantimicag.2021.106512. Epub 2021 Dec 28. PMID: 34971728.
Copy Download .nbib Format: NLM
Position Statement of the Latin American Federation of Endocrinology on Osteoporosis: Response to comments by López Gavilánez.

Archives of osteoporosis

Gómez O, Páez-Talero A, Zanchetta MB, Madeira M, Moreira CA, Campusano C, Medina-Orjuela A, Cerdas S, de la Peña-Rodríguez MP, Reza-Albarrán AA, Velazco C, Mendoza B, Uzcátegui-Osorio LR, Rueda-Plata PN.
PMID: 34888731
Arch Osteoporos. 2021 Dec 10;17(1):3. doi: 10.1007/s11657-021-01011-7.

No abstract available.

Cite
Gómez O, Páez-Talero A, Zanchetta MB, et al. Position Statement of the Latin American Federation of Endocrinology on Osteoporosis: Response to comments by López Gavilánez. Arch Osteoporos. 2021;17(1):3doi: 10.1007/s11657-021-01011-7.
Gómez, O., Páez-Talero, A., Zanchetta, M. B., Madeira, M., Moreira, C. A., Campusano, C., Medina-Orjuela, A., Cerdas, S., de la Peña-Rodríguez, M. P., Reza-Albarrán, A. A., Velazco, C., Mendoza, B., Uzcátegui-Osorio, L. R., & Rueda-Plata, P. N. (2021). Position Statement of the Latin American Federation of Endocrinology on Osteoporosis: Response to comments by López Gavilánez. Archives of osteoporosis, 17(1), 3. https://doi.org/10.1007/s11657-021-01011-7
Gómez, Oscar, et al. "Position Statement of the Latin American Federation of Endocrinology on Osteoporosis: Response to comments by López Gavilánez." Archives of osteoporosis vol. 17,1 (2021): 3. doi: https://doi.org/10.1007/s11657-021-01011-7
Gómez O, Páez-Talero A, Zanchetta MB, Madeira M, Moreira CA, Campusano C, Medina-Orjuela A, Cerdas S, de la Peña-Rodríguez MP, Reza-Albarrán AA, Velazco C, Mendoza B, Uzcátegui-Osorio LR, Rueda-Plata PN. Position Statement of the Latin American Federation of Endocrinology on Osteoporosis: Response to comments by López Gavilánez. Arch Osteoporos. 2021 Dec 10;17(1):3. doi: 10.1007/s11657-021-01011-7. PMID: 34888731.
Copy Download .nbib Format: NLM
Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study.

Life (Basel, Switzerland)

Macera M, Calò F, Onorato L, Di Caprio G, Monari C, Russo A, Galdieri A, Giordano A, Cuccaro P, Coppola N.
PMID: 34073866
Life (Basel). 2021 May 24;11(6). doi: 10.3390/life11060475.

The objectives of the present study were to provide a snapshot analysis of antibiotic appropriateness in two hospitals in Southern Italy in three specific areas, surgical, medical and intensive care, and to evaluate the risk factors associated with inappropriateness...

Cite
Macera M, Calò F, Onorato L, et al. Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study. Life (Basel). 2021;11(6)doi: 10.3390/life11060475.
Macera, M., Calò, F., Onorato, L., Di Caprio, G., Monari, C., Russo, A., Galdieri, A., Giordano, A., Cuccaro, P., & Coppola, N. (2021). Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study. Life (Basel, Switzerland), 11(6), . https://doi.org/10.3390/life11060475
Macera, Margherita, et al. "Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study." Life (Basel, Switzerland) vol. 11,6 (2021). doi: https://doi.org/10.3390/life11060475
Macera M, Calò F, Onorato L, Di Caprio G, Monari C, Russo A, Galdieri A, Giordano A, Cuccaro P, Coppola N. Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study. Life (Basel). 2021 May 24;11(6). doi: 10.3390/life11060475. PMID: 34073866; PMCID: PMC8225033.
Copy Download .nbib Format: NLM
Correction to: HBV molecular epidemiology and clinical condition of immigrants living in Italy.

Infection

Sagnelli C, Ciccozzi M, Alessio L, Cella E, Gualdieri L, Pisaturo M, Minichini C, Di Caprio G, Starace M, Onorato L, Caroprese M, Occhiello L, Angeletti S, Scotto G, Macera M, Sagnelli E, Coppola N.
PMID: 31641957
Infection. 2020 Feb;48(1):147. doi: 10.1007/s15010-019-01365-8.

The original version of this article unfortunately contained a mistake. The name of the author Mara Caroprese was rendered wrongly. The correct name is shown above.

Cite
Sagnelli C, Ciccozzi M, Alessio L, et al. Correction to: HBV molecular epidemiology and clinical condition of immigrants living in Italy. Infection. 2020;48(1):147doi: 10.1007/s15010-019-01365-8.
Sagnelli, C., Ciccozzi, M., Alessio, L., Cella, E., Gualdieri, L., Pisaturo, M., Minichini, C., Di Caprio, G., Starace, M., Onorato, L., Caroprese, M., Occhiello, L., Angeletti, S., Scotto, G., Macera, M., Sagnelli, E., & Coppola, N. (2020). Correction to: HBV molecular epidemiology and clinical condition of immigrants living in Italy. Infection, 48(1), 147. https://doi.org/10.1007/s15010-019-01365-8
Sagnelli, Caterina, et al. "Correction to: HBV molecular epidemiology and clinical condition of immigrants living in Italy." Infection vol. 48,1 (2020): 147. doi: https://doi.org/10.1007/s15010-019-01365-8
Sagnelli C, Ciccozzi M, Alessio L, Cella E, Gualdieri L, Pisaturo M, Minichini C, Di Caprio G, Starace M, Onorato L, Caroprese M, Occhiello L, Angeletti S, Scotto G, Macera M, Sagnelli E, Coppola N. Correction to: HBV molecular epidemiology and clinical condition of immigrants living in Italy. Infection. 2020 Feb;48(1):147. doi: 10.1007/s15010-019-01365-8. PMID: 31641957.
Copy Download .nbib Format: NLM
St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem.

Cancer discovery

McLeod C, Gout AM, Zhou X, Thrasher A, Rahbarinia D, Brady SW, Macias M, Birch K, Finkelstein D, Sunny J, Mudunuri R, Orr BA, Treadway M, Davidson B, Ard TK, Chiao A, Swistak A, Wiggins S, Foy S, Wang J, Sioson E, Wang S, Michael JR, Liu Y, Ma X, Patel A, Edmonson MN, Wilkinson MR, Frantz AM, Chang TC, Tian L, Lei S, Islam SMA, Meyer C, Thangaraj N, Tater P, Kandali V, Ma S, Nguyen T, Serang O, McGuire I, Robison N, Gentry D, Tang X, Palmer LE, Wu G, Suh E, Tanner L, McMurry J, Lear M, Pappo AS, Wang Z, Wilson CL, Cheng Y, Meshinchi S, Alexandrov LB, Weiss MJ, Armstrong GT, Robison LL, Yasui Y, Nichols KE, Ellison DW, Bangur C, Mullighan CG, Baker SJ, Dyer MA, Miller G, Newman S, Rusch M, Daly R, Perry K, Downing JR, Zhang J.
PMID: 33408242
Cancer Discov. 2021 May;11(5):1082-1099. doi: 10.1158/2159-8290.CD-20-1230. Epub 2021 Jan 06.

Effective data sharing is key to accelerating research to improve diagnostic precision, treatment efficacy, and long-term survival in pediatric cancer and other childhood catastrophic diseases. We present St. Jude Cloud (https://www.stjude.cloud), a cloud-based data-sharing ecosystem for accessing, analyzing, and...

Cite
McLeod C, Gout AM, Zhou X, et al. St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem. Cancer Discov. 2021;11(5):1082-1099doi: 10.1158/2159-8290.CD-20-1230.
McLeod, C., Gout, A. M., Zhou, X., Thrasher, A., Rahbarinia, D., Brady, S. W., Macias, M., Birch, K., Finkelstein, D., Sunny, J., Mudunuri, R., Orr, B. A., Treadway, M., Davidson, B., Ard, T. K., Chiao, A., Swistak, A., Wiggins, S., Foy, S., Wang, J., Sioson, E., Wang, S., Michael, J. R., Liu, Y., Ma, X., Patel, A., Edmonson, M. N., Wilkinson, M. R., Frantz, A. M., Chang, T. C., Tian, L., Lei, S., Islam, S. M. A., Meyer, C., Thangaraj, N., Tater, P., Kandali, V., Ma, S., Nguyen, T., Serang, O., McGuire, I., Robison, N., Gentry, D., Tang, X., Palmer, L. E., Wu, G., Suh, E., Tanner, L., McMurry, J., Lear, M., Pappo, A. S., Wang, Z., Wilson, C. L., Cheng, Y., Meshinchi, S., Alexandrov, L. B., Weiss, M. J., Armstrong, G. T., Robison, L. L., Yasui, Y., Nichols, K. E., Ellison, D. W., Bangur, C., Mullighan, C. G., Baker, S. J., Dyer, M. A., Miller, G., Newman, S., Rusch, M., Daly, R., Perry, K., Downing, J. R., & Zhang, J. (2021). St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem. Cancer discovery, 11(5), 1082-1099. https://doi.org/10.1158/2159-8290.CD-20-1230
McLeod, Clay, et al. "St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem." Cancer discovery vol. 11,5 (2021): 1082-1099. doi: https://doi.org/10.1158/2159-8290.CD-20-1230
McLeod C, Gout AM, Zhou X, Thrasher A, Rahbarinia D, Brady SW, Macias M, Birch K, Finkelstein D, Sunny J, Mudunuri R, Orr BA, Treadway M, Davidson B, Ard TK, Chiao A, Swistak A, Wiggins S, Foy S, Wang J, Sioson E, Wang S, Michael JR, Liu Y, Ma X, Patel A, Edmonson MN, Wilkinson MR, Frantz AM, Chang TC, Tian L, Lei S, Islam SMA, Meyer C, Thangaraj N, Tater P, Kandali V, Ma S, Nguyen T, Serang O, McGuire I, Robison N, Gentry D, Tang X, Palmer LE, Wu G, Suh E, Tanner L, McMurry J, Lear M, Pappo AS, Wang Z, Wilson CL, Cheng Y, Meshinchi S, Alexandrov LB, Weiss MJ, Armstrong GT, Robison LL, Yasui Y, Nichols KE, Ellison DW, Bangur C, Mullighan CG, Baker SJ, Dyer MA, Miller G, Newman S, Rusch M, Daly R, Perry K, Downing JR, Zhang J. St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem. Cancer Discov. 2021 May;11(5):1082-1099. doi: 10.1158/2159-8290.CD-20-1230. Epub 2021 Jan 06. PMID: 33408242; PMCID: PMC8102307.
Copy Download .nbib Format: NLM
Masson's Lesion: A Very Rare Cardiac Mass.

The Canadian journal of cardiology

Albuquerque F, Freitas P, Albuquerque C, Ramos S, Madeira M, Neves JP.
PMID: 34648876
Can J Cardiol. 2021 Oct 12; doi: 10.1016/j.cjca.2021.09.035. Epub 2021 Oct 12.

Masson lesion is a rare type of vascular tumour usually found in the skin and soft tissues. Histologic examination remains the gold standard for diagnosis. Treatment involves complete surgical excision, and correct diagnosis is essential to avoid unnecessary aggressive...

Cite
Albuquerque F, Freitas P, Albuquerque C, et al. Masson's Lesion: A Very Rare Cardiac Mass. Can J Cardiol. 2021;doi: 10.1016/j.cjca.2021.09.035.
Albuquerque, F., Freitas, P., Albuquerque, C., Ramos, S., Madeira, M., & Neves, J. P. (2021). Masson's Lesion: A Very Rare Cardiac Mass. The Canadian journal of cardiology, . https://doi.org/10.1016/j.cjca.2021.09.035
Albuquerque, Francisco, et al. "Masson's Lesion: A Very Rare Cardiac Mass." The Canadian journal of cardiology vol. (2021). doi: https://doi.org/10.1016/j.cjca.2021.09.035
Albuquerque F, Freitas P, Albuquerque C, Ramos S, Madeira M, Neves JP. Masson's Lesion: A Very Rare Cardiac Mass. Can J Cardiol. 2021 Oct 12; doi: 10.1016/j.cjca.2021.09.035. Epub 2021 Oct 12. PMID: 34648876.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 91 entries